Balance Sheet Data
Agios Pharmaceuticals, Inc. (AGIO)
$22.14
+0.02 (+0.09%)
Year A/P | 2017 Actual | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected |
| Total Cash | 423.94 | 585.30 | 564.88 | 572.93 | 1,020.02 | 263.79 | 340.76 | 440.19 | 568.64 | 734.58 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | 3.84 | 10.44 | 15.32 | 25.40 | 0 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 |
| Account Receivables (%) | ||||||||||
| Inventories | - | 0.87 | 7.33 | 14.70 | 0 | 0 | 0 | 0 | 0.01 | 0.01 |
| Inventories (%) | ||||||||||
| Accounts Payable | 22.77 | 17.88 | 21.90 | 26.84 | 16.70 | 4.33 | 5.59 | 7.22 | 9.32 | 12.05 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | -4.63 | -6.99 | -12.17 | -14.91 | -5.74 | -1.49 | -1.92 | -2.48 | -3.21 | -4.14 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.